BC
Brinker Capital Portfolio holdings
AUM
$3.13B
Turnover
16.67%
1-Year Est. Return
9.04%
This Fund
S&P 500
This Quarter
Est. Return
+21.71%
1 Year Est. Return
+9.04%
3 Year Est. Return
+36.1%
5 Year Est. Return
+56.66%
10 Year Est. Return
–
AUM
$3.13B
AUM Growth
+$624M
(+25%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
4.25%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
1,002
New
95
Increased
529
Reduced
305
Closed
72
Avg Time Held
2.3
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$15.2M |
| 2 |
iShares MBS ETF
MBB
|
+$13.9M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$9.82M |
| 4 |
Invesco Preferred ETF
PGX
|
+$8.16M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$29.5M |
| 2 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
+$14.6M |
| 3 |
Booking.com
BKNG
|
+$7.56M |
| 4 |
TJX Companies
TJX
|
+$6.46M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$5.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.66% |
| 2 | Technology | 15.39% |
| 3 | Healthcare | 11.95% |
| 4 | Financials | 8.26% |
| 5 | Industrials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Canadian National Railway
CNI
$72.4B
| $2.36M | 0.08% |
26,631
-3,141
| -11% | -$261K |
2016 Q3
15 quarters
|
|
252
FedEx
FDX
$68.9B
| $2.36M | 0.08% |
16,809
+3,316
| +25% | +$417K |
2017 Q3
11 quarters
|
|
253
Weyerhaeuser
WY
$13.6B
| $2.35M | 0.08% |
104,697
+25,061
| +31% | +$507K |
2019 Q2
4 quarters
|
|
254
Fortune Brands Innovations
FBIN
$4.63B
| $2.3M | 0.07% |
42,106
+367
| +0.9% | +$17.1K |
2018 Q4
6 quarters
|
|
255
Verisk Analytics
VRSK
$23.5B
| $2.29M | 0.07% |
13,443
+214
| +2% | +$33.8K |
2016 Q1
17 quarters
|
|
256
Republic Services
RSG
$68.7B
| $2.28M | 0.07% |
27,765
+133
| +0.5% | +$10.7K |
2018 Q1
9 quarters
|
|
257
Roper Technologies
ROP
$36.9B
| $2.28M | 0.07% |
5,877
+1,002
| +21% | +$359K |
2017 Q3
11 quarters
|
|
258
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.28M | 0.07% |
130,142
+7,382
| +6% | +$120K |
2017 Q1
13 quarters
|
|
|
VAR
259
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.28M | 0.07% |
18,599
+149
| +0.8% | +$17.3K |
2015 Q4
18 quarters
|
|
260
LyondellBasell Industries
LYB
$19.8B
| $2.27M | 0.07% |
+34,610
| New | +$2.06M |
2020 Q2
0 quarters
|
|
261
Goldman Sachs
GS
$256B
| $2.26M | 0.07% |
11,451
+1,497
| +15% | +$281K |
2015 Q4
18 quarters
|
|
262
Vertex Pharmaceuticals
VRTX
$126B
| $2.26M | 0.07% |
7,794
-2,446
| -24% | -$663K |
2015 Q4
18 quarters
|
|
263
American Water Works
AWK
$26.2B
| $2.26M | 0.07% |
17,545
+8,961
| +104% | +$1.12M |
2016 Q4
14 quarters
|
|
264
Eastman Chemical
EMN
$7.19B
| $2.25M | 0.07% |
32,119
+3,021
| +10% | +$190K |
2019 Q3
3 quarters
|
|
265
Amdocs
DOX
$6.19B
| $2.25M | 0.07% |
36,850
-9,232
| -20% | -$570K |
2019 Q2
4 quarters
|
|
266
NewMarket
NEU
$8.19B
| $2.24M | 0.07% |
5,591
+169
| +3% | +$69.7K |
2017 Q3
11 quarters
|
|
267
Textron
TXT
$12.7B
| $2.24M | 0.07% |
67,972
+21,494
| +46% | +$635K |
2015 Q4
18 quarters
|
|
268
T-Mobile US
TMUS
$169B
| $2.23M | 0.07% |
21,444
-489
| -2% | -$46.9K |
2018 Q2
8 quarters
|
|
269
Jazz Pharmaceuticals
JAZZ
$13.6B
| $2.23M | 0.07% |
20,213
+484
| +2% | +$53.5K |
2017 Q4
10 quarters
|
|
270
Cummins
CMI
$72.4B
| $2.21M | 0.07% |
12,783
-311
| -2% | -$49.7K |
2017 Q3
11 quarters
|
|
271
WEX
WEX
$5.95B
| $2.21M | 0.07% |
13,417
+789
| +6% | +$108K |
2017 Q3
11 quarters
|
|
272
Charles Schwab
SCHW
$167B
| $2.21M | 0.07% |
65,501
+7,964
| +14% | +$285K |
2016 Q1
17 quarters
|
|
273
Exponent
EXPO
$3.38B
| $2.19M | 0.07% |
27,066
-11,306
| -29% | -$814K |
2017 Q1
13 quarters
|
|
274
Cognex
CGNX
$9.63B
| $2.18M | 0.07% |
36,506
+1,411
| +4% | +$76.6K |
2017 Q1
13 quarters
|
|
275
Western Alliance Bancorporation
WAL
$7.88B
| $2.18M | 0.07% |
57,560
+975
| +2% | +$34.1K |
2016 Q4
14 quarters
|
|
Similar funds
SCRM
FIM
GFPC
IC
I
MC
FTI
AWM
Brinker Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Brinker Capital held 1,002 positions worth $3.13B, up 25% from $2.51B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brinker Capital deployed $133M of net new capital in Q2 2020, opening 95 new positions and adding to 529 existing holdings. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 282,435 shares worth $15.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Schwab Short-Term US Treasury ETF, an estimated $29.5M trimmed.
- Brinker Capital's largest Q2 2020 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 282,435 shares worth $15.5M.
- Brinker Capital added most to Vanguard Short-Term Corporate Bond ETF in Q2 2020, an estimated $9.82M increase.
- Brinker Capital's biggest Q2 2020 reduction was Schwab Short-Term US Treasury ETF, cutting an estimated $29.5M.
- Brinker Capital fully exited iShares Intermediate Government/Credit Bond ETF in Q2 2020, selling an estimated $14.6M.
- Brinker Capital's ten largest holdings make up 23% of its $3.13B portfolio in Q2 2020.
- Brinker Capital opened 95 new positions and closed 72 in Q2 2020.
- Brinker Capital's portfolio value rose 25% quarter-over-quarter to $3.13B.
Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.